Fundz

Scarlet Therapeutics Raises £3.2m in Funding led by Eos Advisory to advance its RBC platform targeting metabolic diseases.

PRIVATEMay 11, 2026

Amount Raised

£3.2 Million

Round Type

Seed

Bristol

Investors

ScvcOshen BioDaft CapitalEos Advisory

Description

Scarlet Therapeutics, a Bristol, UK-based biotechnology company developing red blood cell (RBC) therapies, raised £3.2M in funding. The round was led by new investor Eos Advisory, with participation from existing investor SCVC, and new investors Oshen Bio and Daft Capital. The company intends to use the funds to advance the first applications of its RBC platform, focusing on multiple metabolic diseases. Proceeds will support in vivo proof-of-concept studies, manufacturing development, and regulatory engagement.

Who to call at Scarlet Therapeutics, and when

A new round usually means Scarlet Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Scarlet Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Scarlet Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Scarlet Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Scarlet Therapeutics

Location

Bristol, England, United Kingdom

About

Scarlet Therapeutics is a biotechnology company based in Bristol, UK, specializing in the development of engineered red blood cell therapies. Founded in 2022, the company was born as a spin-off of the University of Bristol and the British National Health Service NHS Blood and Transplant. Scarlet Therapeutics aims to create donor-independent blood products targeting metabolic diseases and has potential applications in treating cancers and autoimmune diseases. The company is advancing its RBC platform through proof-of-concept studies and regulatory engagement.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Scarlet Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsAlistair I., CEO hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Scarlet Therapeutics's next move

See what Strategic adds

Scarlet Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.